Bain Capital Life Sciences

Bain Capital Life Sciences

Bain Capital Life Sciences

Suggest edits
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 12

Portfolio

Portfolio Tracker

Add info
Add round
16 Jun 2020
C4 Therapeutics
C4 Therapeutics
$150,000,000
Venture capital (Series B)
Adage Capital Management, RA Capital Management, Perceptive Advisors, +16

C4 Therapeutics Raises $170M in Funding

FinSMEs
+1
26 May 2020
ViaCyte
ViaCyte
$27,000,000
Venture capital (Series D)
RA Capital Management, Sanderling Ventures, TPG Capital, +1

ViaCyte Closes Approximately $27M in Series D Financing

FinSMEs
20 May 2020
Rapid Micro Biosystems
Rapid Micro Biosystems
$120,000,000
Venture capital
Endeavour Vision, Xeraya Capital, Longitude Capital, +3

Rapid Micro Biosystems Raises $120M in Funding

FinSMEs
+1
23 Apr 2020
Affinivax
Affinivax
$120,000,000
Venture capital (Series B)
Viking Global Investors, Bain Capital Life Sciences, Ziff Capital Partners

Affinivax Raises $120M in Series B Funding

FinSMEs
12 Mar 2020
Kymera Therapeutics
Kymera Therapeutics
$102,000,000
Venture capital (Series C)
Redmile Group, BlackRock, Wellington Management, +4

Kymera Therapeutics Raises $102M in Series C Financing

FinSMEs
19 Dec 2018
Annexon Biosciences
Annexon Biosciences
$75,000,000
Venture capital (Series C)
Novartis Venture Fund, Bain Capital Life Sciences, New Enterprise Associates, +3

Annexon Biosciences takes in $75 mln Series C

PE HUB
30 Nov 2018
ViaCyte
ViaCyte
$80,000,000
Venture capital (Series D)
RA Capital Management, TPG, Bain Capital Life Sciences

ViaCyte nabs $80 mln Series D

PE HUB
02 May 2018
Rapid Micro Biosystems
Rapid Micro Biosystems
$60,000,000
Venture capital
Xeraya Capital, Longitude Capital, TVM Capital, +4

Rapid Micro Biosystems Secures $60M in Equity Financing

FinSMEs
+1
18 Dec 2017
Aptinyx Inc.
Aptinyx Inc.
$70,000,000
Venture capital (Series B)
Adams Street Partners, Osage University Partners, Frazier Healthcare Partners, +13

| Aptinyx lands $70 mln Series B

PE HUB
+1
25 Sep 2017
SpringWorks Therapeutics
SpringWorks Therapeutics
$103,000,000
Venture capital (Series A)
OrbiMed, Pfizer, Bain Capital Life Sciences, +2
30 Mar 2017
Dicerna Pharma
Dicerna Pharma
$70,000,000
Post-IPO equity
RA Capital Management, Skyline Ventures, Domain Associates, +3

Dicerna scores $70 mln

PE HUB
30 Mar 2017
Solid GT
Solid GT
$50,000,000
Venture capital (Series C)
Foresite Capital, RA Capital Management, Janus Capital Group, +6

Solid Biosciences Raises Up To $50 Million In Series C Financing

Solid Biosciences